CRT - 2014
7:00 PM America/New_York
A Critical Evaluation of Bifurcation Trials and the State of Our Knowledge
AHA 2014 Interview: Dean Kereiakes, MD
Works at The Christ Hospital Heart and Vascular Center/The Lindner Research Center, Cincinnati, OH, USA. Features in 20 videos on Wondr Medical. Dean Kereiakes generally speaks on Drug Eluting Stents (DES), Coronary Interventions, Bioresorbable Vascular Scaffold (BVS), Intracoronary Imaging, and Anti-Platelet Drugs .
An internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.
2020 All rights reserved